Clinical Trial

Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study

Study acronym: BIOLIMEN-1
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of the clinical trial is to assess the presence of circulating tumor cells (CTCs) in the blood and/or cerebrospinal fluid (CSF) of patients with aggressive recurrent meningiomas.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-15
notable Primary completion pushed: 2027-07 -> 2027-10 2026-07-15
minor Completion pushed: 2027-07 -> 2027-10 2026-07-15
Trial Details
NCT Number NCT07398170
Lead Sponsor University Hospital, Montpellier
Conditions Meningioma
Enrollment 15 participants
Start Date 2026-07-13
Primary Completion 2027-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-14